Company Data

Viridian Therapeutics Inc.

Ticker
VRDN
Current Price
$18.38 -0.33%
Market Cap
$1.5B
Price Target
Refer to Report
Volume
649.7K
52wk Range
$9.9 - $27.2
Advanced Market Data

Overview

Viridian Therapeutics Inc is a clinical-stage biopharmaceutical company that engages in developing multiple product candidates to treat patients who suffer from thyroid eye disease. Its product candidate VRDN-001 is an insulin-like growth factor-1 receptor (IGF-1R) monoclonal antibody (mAb) being developed for the potential treatment for patients with thyroid eye disease.

Inbox Intel from Channelchek.

Informed investors make more money. And it’s all about timing. Get it when it happens.

By clicking submit you are agreeing to the Terms of Use and Privacy Policy